Tom 6, Nr 2 (2021)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2021-09-01
Wyświetlenia strony 4063
Wyświetlenia/pobrania artykułu 557
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Rekomendacje Polskiego Towarzystwa Ginekologów i Położników dotyczące indukcji porodu. Aktualizacja 2021

Dorota Bomba-Opoń1, Krzysztof Drews2, Hubert Huras3, Piotr Laudański4, Tomasz Paszkowski5, Mirosław Wielgoś1, Tomasz Fuchs6, Michał Pomorski6, Mariusz Zimmer6
Ginekologia i Perinatologia Praktyczna 2021;6(2):86-99.

Streszczenie

Brak

Artykuł dostępny w formacie PDF

Dodaj do koszyka: 49,00 PLN

Posiadasz dostęp do tego artykułu?

Referencje

  1. Nicholson JM, Kellar LC, Henning GF, et al. The association between the regular use of preventive labour induction and improved term birth outcomes: findings of a systematic review and meta-analysis. BJOG. 2015; 122(6): 773–784.
  2. Whitworth M, Bricker L, Neilson JP. Ultrasound for fetal assessment in early pregnancy. Cochrane Database Syst Rev. 2000(2): CD000182.
  3. Caughey AB, Nicholson JM, Washington AE. First- vs second-trimester ultrasound: the effect on pregnancy dating and perinatal outcomes. Am J Obstet Gynecol. 2008; 198(6): 703.e1–5; discussion 703.e5.
  4. Blondel B, Morin I, Platt RW, et al. Algorithms for combining menstrual and ultrasound estimates of gestational age: consequences for rates of preterm and postterm birth. BJOG. 2002; 109(6): 718–720.
  5. Gülmezoglu AM, Crowther CA, Middleton P, et al. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev. 2006(4): CD004945.
  6. Rozporządzenie Ministra Zdrowia z dnia 20 września 2012 r. w sprawie standardów postępowania medycznego przy udzie laniu świadczeń zdrowotnych z zakresu opieki okołoporodowej sprawowanej nad kobietą w okresie fizjologicznej ciąży, fizjologicznego porodu, połogu oraz opieki nad noworodkiem. Dz.U.12.1100.
  7. Rozporządzenie Ministra Zdrowia z dnia 16 sierpnia 2018 r. w sprawie standardu organizacyjnego opieki okołoporodowej Dz.U. dnia 11 września 2018 r. Poz. 1756.
  8. Rozporządzenie Ministra Zdrowia z dnia 9 listopada 2015 r. w sprawie standardów postępowania medycznego przy udzielaniu świadczeń zdrowotnych w dziedzinie położnictwa i ginekologii z zakresu okołoporodowej opieki położniczo-ginekologicznej, sprawowanej nad kobietą w okresie ciąży, porodu, połogu, w przypadkach występowania określonych powikłań oraz opieki nad kobietą w sytuacji niepowodzeń położniczych. Dz.U. 2015, poz. 2007.
  9. Bond DM, Middleton P, Levett KM. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2010(3): CD004735.
  10. van der Ham DP, van der Heyden JL, Opmeer BC, et al. Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial. Am J Obstet Gynecol. 2012; 207(4): 276.e1–276.10.
  11. Morris J, Roberts C, Bowen J, et al. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. The Lancet. 2016; 387(10017): 444–452.
  12. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006(3): CD004454.
  13. Lee MJ, Davies J, Guinn D. Single versus weekly courses of antenatal corticosteroids in preterm premature rupture of membranes. Obstet Gynecol. 2004; 103(2): 274–281.
  14. Kenyon S, Boulvain M, Neilson J, et al. Antibiotics for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2000(2): CD001058.
  15. Hannah ME, Ohlsson A, Farine D, et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med. 1996; 334(16): 1005–1010.
  16. Middleton P, Shepherd E, Flenady V, et al. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev. 2017; 1: CD005302, doi: 10.1002/14651858.CD005302. pub3, indexed in Pubmed: 28050900.
  17. Di Renzo GC, Melin P, Berardi A, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med. 2015; 28(7): 766–782.
  18. Ju H, Chadha Y, Donovan T, et al. Fetal macrosomia and pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2009; 49(5): 504–509.
  19. Das S, Irigoyen M, Patterson MB, et al. Neonatal outcomes of macrosomic births in diabetic and non-diabetic women. Arch Dis Child Fetal Neonatal Ed. 2009; 94(6): F419–F422.
  20. Drooger JC, Troe JWM, Borsboom GJ, et al. Ethnic differences in prenatal growth and the association with maternal and fetal characteristics. Ultrasound Obstet Gynecol. 2005; 26(2): 115–122.
  21. Vora N, Bianchi DW. Genetic considerations in the prenatal diagnosis of overgrowth syndromes. Prenat Diagn. 2009; 29(10): 923–929.
  22. Pinette MG, Pan Y, Pinette SG, et al. Estimation of fetal weight: mean value from multiple formulas. J Ultrasound Med. 1999; 18(12): 813–817.
  23. Coomarasamy A, Connock M, Thornton J, et al. Accuracy of ultrasound biometry in the prediction of macrosomia: a systematic quantitative review. BJOG. 2005; 112(11): 1461–1466.
  24. Boulvain M, Senat MV, Perrotin F, et al. Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. The Lancet. 2015; 385(9987): 2600–2605.
  25. Boulvain M, Irion O, Dowswell T, et al. Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database Syst Rev. 2016(5): CD000938.
  26. Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol. 1998; 179(2): 476–480.
  27. Turan S, Miller J, Baschat AA. Integrated testing and management in fetal growth restriction. Semin Perinatol. 2008; 32(3): 194–200.
  28. Lees C, Marlow N, Arabin B, et al. TRUFFLE Group. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013; 42(4): 400–408.
  29. Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014; 36(2): 86–98.
  30. Joseph KS, Liu S, Demissie K, et al. The Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System . A parsimonious explanation for intersecting perinatal mortality curves: understanding the effect of plurality and of parity. BMC Pregnancy Childbirth. 2003; 3(1): 3.
  31. Burgess JL, Unal ER, Nietert PJ, et al. Risk of late-preterm stillbirth and neonatal morbidity for monochorionic and dichorionic twins. Am J Obstet Gynecol. 2014; 210(6): 578.e1–578.e9.
  32. Hack KEA, Derks JB, Elias SG, et al. Perinatal mortality and mode of delivery in monochorionic diamniotic twin pregnancies ≥ 32 weeks of gestation: a multicentre retrospective cohort study. BJOG. 2011; 118(9): 1090–1097.
  33. Rossi AC, Prefumo F. Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature. Ultrasound Obstet Gynecol. 2013; 41(2): 131–135.
  34. Vilchez GA, Dai J, Hoyos LR, et al. Optimal timing for term delivery of twin pregnancies: a population-based study. Am J Perinatol. 2015; 32(5): 487–496.
  35. Wood S, Tang S, Ross S, et al. Stillbirth in twins, exploring the optimal gestational age for delivery: a retrospective cohort study. BJOG. 2014; 121(10): 1284–90; discussion 1291.
  36. Dodd JM, Crowther CA, Haslam RR, et al. Twins Timing of Birth Trial Group. Elective birth at 37 weeks of gestation versus standard care for women with an uncomplicated twin pregnancy at term: the Twins Timing of Birth Randomised Trial. BJOG. 2012; 119(8): 964–973.
  37. Hoffmann E, Oldenburg A, Rode L, et al. Twin births: cesarean section or vaginal delivery? Acta Obstet Gynecol Scand. 2012; 91(4): 463–469.
  38. Barrett JFR, Hannah ME, Hutton EK, et al. Twin Birth Study Collaborative Group. A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med. 2013; 369(14): 1295–1305.
  39. Hutcheon JA, Lisonkova S, Magee LA, et al. Optimal timing of delivery in pregnancies with pre-existing hypertension. BJOG. 2011; 118(1): 49–54.
  40. Koopmans C, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. The Lancet. 2009; 374(9694): 979–988.
  41. Burkhardt T, Schmidt M, Kurmanavicius J, et al. Evaluation of fetal anthropometric measures to predict the risk for shoulder dystocia. Ultrasound Obstet Gynecol. 2014; 43(1): 77–82.
  42. Kjos SL, Henry OA, Montoro M, et al. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol. 1993; 169(3): 611–615.
  43. Sutton AL, Mele L, Landon MB, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Delivery timing and cesarean delivery risk in women with mild gestational diabetes mellitus. Am J Obstet Gynecol. 2014; 211(3): 244.e1–244.e7.
  44. Melamed N, Ray JG, Geary M, et al. Induction of labor before 40 weeks is associated with lower rate of cesarean delivery in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2016; 214(3): 364.e1–364.e8.
  45. Kawakita T, Parikh LI, Ramsey PS, et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2015; 213(4): 570.e1–570.e8.
  46. Puljic A, Kim E, Page J, et al. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol. 2015; 212(5): 667.e1–667.e5.
  47. Lo JO, Shaffer BL, Allen AJ, et al. Intrahepatic cholestasis of pregnancy and timing of delivery. J Matern Fetal Neonatal Med. 2015; 28(18): 2254–2258.
  48. Friberg AK, Zingmark V, Lyndrup J. Early induction of labor in high-risk intrahepatic cholestasis of pregnancy: what are the costs? Arch Gynecol Obstet. 2016; 294(4): 709–714.
  49. Walker KF, Bugg G, Macpherson M, et al. Induction of labour versus expectant management for nulliparous women over 35 years of age: a multi-centre prospective, randomised controlled trial. BMC Pregnancy Childbirth. 2012; 12: 145.
  50. Walker KF, Bugg GJ, Macpherson M, et al. 35/39 Trial Group. Randomized Trial of Labor Induction in Women 35 Years of Age or Older. N Engl J Med. 2016; 374(9): 813–822.
  51. Walker KF, Malin G, Wilson P, et al. Induction of labour versus expectant management at term by subgroups of maternal age: an individual patient data meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2016; 197: 1–5.
  52. Bishop EH. Pelvic scoring fo elective induction. Obstet Gynecol. 1964; 24: 266–268.
  53. Ezebialu IU, Eke AC, Eleje GU, et al. Methods for assessing pre-induction cervical ripening. Cochrane Database Syst Rev. 2015(6): CD010762.
  54. Alfirevic Z, Keeney E, Dowswell T, et al. Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess. 2016; 20(65): 1–584.
  55. Jozwiak M, Bloemenkamp KWM, Kelly AJ, et al. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2012(3): CD001233.
  56. Du C, Liu Y, Liu Y, et al. Double-balloon catheter vs. dinoprostone vaginal insert for induction of labor with an unfavorable cervix. Arch Gynecol Obstet. 2015; 291(6): 1221–1227.
  57. Boulvain M, Kelly A, Irion O. Intracervical prostaglandins for induction of labour. Cochrane Database Syst Rev. 2008(1): CD006971.
  58. Thomas J, Fairclough A, Kavanagh J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev. 2014; 6(CD003101).
  59. Alfirevic Z, Kelly AJ, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2001(3): CD003246.
  60. Budden A, Chen L, Henry A. High-dose versus low-dose oxytocin infusion regimens for induction of labour at term. Cochrane Database Syst Rev. 2014; 10(CD009701).
  61. Daniel-Spiegel E, Weiner Z, Ben-Shlomo I, et al. For how long should oxytocin be continued during induction of labour? BJOG. 2004; 111(4): 331–334.
  62. Boulvain M, Stan C, Irion O, et al. Stripping/sweeping the membranes for inducing labour or preventing post-term pregnancy. Cochrane Database Syst Rev. 2000(2): CD000451.
  63. Bricker L, Luckas M. Amniotomy alone for induction of labour. Cochrane Database Syst Rev. 2000(4): CD002862.
  64. Battarbee AN, Palatnik A, Peress DA, et al. Association of Early Amniotomy After Foley Balloon Catheter Ripening and Duration of Nulliparous Labor Induction. Obstet Gynecol. 2016; 128(3): 592–597.
  65. Beckmann M, Merollini K, Kumar S, et al. Induction of labor using prostaglandin vaginal gel: cost analysis comparing early amniotomy with repeat prostaglandin gel. Eur J Obstet Gynecol Reprod Biol. 2016; 199: 96–101.
  66. WHO recommendations for induction of labour, 2011. www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241501156/en/.



Ginekologia i Perinatologia Praktyczna